This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Bos taurus
Homo sapiens
Mus musculus
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
Bone marrow stromal cells
Breast cancer cell (MCF7)
Breast cancer cells (4T1)
Breast cancer cells (MCF7)
Breast cancer cells (MDA-MB-231)
Caput epithelial cell
Caput luminal fluid
Cauda epithelial cell
Cauda luminal fluid
Colon cancer cell (SW48)
Drug-resistant acute lymphoblastic leukemia cell (CCRF-CEM MDR variant VLB100)
Drug-resistant breast adenocarcinoma cell (MCF-7 MDR variant MCF-7/DX)
Fetal human colon epithelial cell (FHC)
Gastric cancer cells (SGC-7901)
Immature bone marrow-derived dendritic cell
Leukemia cell (K562)
Liver cancer cells (CSQT-2)
Liver cancer cells (MHCC-97L)
Mammary gland cells (MCF10A)
Mammary gland cells (NMuMG)
Mature bone marrow-derived dendritic cell
Metastatic gastric cancer cell (AZ521)
Multiple myeloma cells (KMS-11)
Multiple myeloma cells (RPMI8226)
Multiple myeloma cells (U266)
Pancreatic cancer cells (KPC)
Pancreatic ductal epithelial cells (MPDC)
Plasma
Seminal plasma
Serum
By sample status
24 hr culture
72 hr culture
Electroporated with Dicer antibody
Extremely severe hand, foot, and mouth disease
Hypoxic condition (24 hr)
Multiple myeloma patients
Normal
Normal_Exiqon
Normal_old
Sample A_Illumina
Sample B_NEB
Sample C_NEB
Survived under long-term hypoxia
Transplant islets into mouse xenotransplantation-rejected
Type 1 diabetes
Vasectomy
Vasovasostomy
shDicer-transfected
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
sme-miR-8a-3p
MIMAT0003972
0.0e+0
3.9e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000019_2
50
/
0
/
50
mmu-miR-200a-3p
MIMAT0000519
0.0e+0
2.7e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000019_2
50
/
0
/
50
rno-miR-141-3p
MIMAT0000846
0.0e+0
2.3e-5
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000019_2
50
/
0
/
50
mmu-miR-141-3p
MIMAT0000153
0.0e+0
0.0e+0
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000019_2
50
/
0
/
50
mmu-miR-200a-3p
MIMAT0000519
0.0e+0
2.1e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000019_2
50
/
0
/
50
sme-miR-8a-3p
MIMAT0003972
0.0e+0
1.0e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000019_2
50
/
0
/
50
hsa-miR-200a-3p
MIMAT0000682
0.0e+0
4.2e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000019_2
50
/
0
/
50
mmu-miR-141-3p
MIMAT0000153
0.0e+0
1.4e-10
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000019_2
50
/
0
/
50
mmu-miR-141-3p
MIMAT0000153
0.0e+0
7.4e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000019_2
50
/
0
/
50
hsa-miR-200a-3p
MIMAT0000682
0.0e+0
4.5e-2
Breast Cancer-Specific miR Signature Unique to Extracellular Vesicles includes microRNA-like tRNA Fragments.
Mol Cancer Res. 2015 Feb 26. pii: molcanres.0533.2014.
MIPF0000019_2
50
/
0
/
50
hsa-miR-200b-3p
MIMAT0000318
0.0e+0
9.3e-5
Breast Cancer-Specific miR Signature Unique to Extracellular Vesicles includes microRNA-like tRNA Fragments.
Mol Cancer Res. 2015 Feb 26. pii: molcanres.0533.2014.
MIPF0000019_2
50
/
0
/
50
hsa-miR-200c-3p
MIMAT0000617
0.0e+0
3.5e-7
Breast Cancer-Specific miR Signature Unique to Extracellular Vesicles includes microRNA-like tRNA Fragments.
Mol Cancer Res. 2015 Feb 26. pii: molcanres.0533.2014.
MIPF0000019_2
50
/
0
/
50
sme-miR-8a-3p
MIMAT0003972
1.4e-15
1.4e-15
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000019_2
50
/
0
/
50
hsa-miR-200c-3p
MIMAT0000617
1.0e-3
1.0e-3
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000019_2
50
/
0
/
50
mmu-miR-429-3p
MIMAT0001537
0.0e+0
4.1e-1
Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.
MIPF0000019_2
50
/
0
/
50
mmu-miR-200b-3p
MIMAT0000233
0.0e+0
9.6e-2
Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.
MIPF0000019_2
50
/
0
/
50
mmu-miR-200c-3p
MIMAT0000657
0.0e+0
3.7e-4
Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.
MIPF0000019_2
50
/
0
/
50
mmu-miR-429-3p
MIMAT0001537
0.0e+0
1.5e-1
Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.
MIPF0000019_2
50
/
0
/
50
hsa-miR-141-3p
MIMAT0000432
1.7e-3
4.3e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000019_2
50
/
0
/
50
hsa-miR-141-3p
MIMAT0000432
1.0e-3
4.4e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000019_2
50
/
0
/
50
hsa-miR-200a-3p
MIMAT0000682
0.0e+0
1.5e-1
Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.
MIPF0000019_2
50
/
0
/
50
hsa-miR-141-3p
MIMAT0000432
4.6e-5
0.0e+0
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000019_2
50
/
0
/
50
hsa-miR-200a-3p
MIMAT0000682
4.6e-5
0.0e+0
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000019_2
50
/
0
/
50
hsa-miR-200b-3p
MIMAT0000318
4.6e-5
0.0e+0
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000019_2
50
/
0
/
50
hsa-miR-141-3p
MIMAT0000432
1.8e-2
1.8e-2
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000019_2
50
/
0
/
50
hsa-miR-200a-3p
MIMAT0000682
1.8e-2
1.8e-2
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000019_2
50
/
0
/
50
hsa-miR-200b-3p
MIMAT0000318
1.8e-2
1.8e-2
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000019_2
50
/
0
/
50
hsa-miR-141-3p
MIMAT0000432
0.0e+0
7.8e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000019_2
50
/
0
/
50
hsa-miR-200a-3p
MIMAT0000682
0.0e+0
1.9e-1
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000019_2
50
/
0
/
50
hsa-miR-200b-3p
MIMAT0000318
0.0e+0
1.2e-1
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000019_2
50
/
0
/
50
hsa-miR-200c-3p
MIMAT0000617
0.0e+0
1.0e-1
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000019_2
50
/
0
/
50
hsa-miR-141-3p
MIMAT0000432
3.1e-2
3.1e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000019_2
50
/
0
/
50
hsa-miR-200b-3p
MIMAT0000318
3.5e-2
3.5e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000019_2
50
/
0
/
50
<
[4]